Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.28 USD | -3.35% | -0.98% | +140.13% |
04-11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
04-03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.13% | 324M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Baird Downgrades Homology Medicines to Neutral From Outperform, Adjusts Price Target to $1.50 From $9